398 related articles for article (PubMed ID: 11773417)
21. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.
Dufour F; Sasseville AM; Chabaud S; Massie B; Siegel RM; Langelier Y
Apoptosis; 2011 Mar; 16(3):256-71. PubMed ID: 21107701
[TBL] [Abstract][Full Text] [Related]
22. A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.
Smith CC; Yu YX; Kulka M; Aurelian L
J Biol Chem; 2000 Aug; 275(33):25690-9. PubMed ID: 10833516
[TBL] [Abstract][Full Text] [Related]
23. An HSV-2-based oncolytic virus deleted in the PK domain of the ICP10 gene is a potent inducer of apoptotic death in tumor cells.
Fu X; Tao L; Zhang X
Gene Ther; 2007 Aug; 14(16):1218-25. PubMed ID: 17538637
[TBL] [Abstract][Full Text] [Related]
24. The protein kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) fused to the extracellular domain of the epidermal growth factor receptor is ligand-inducible.
Smith CC; Luo JH; Aurelian L
Virology; 1996 Mar; 217(2):425-34. PubMed ID: 8610433
[TBL] [Abstract][Full Text] [Related]
25. Cell type-specific induction and inhibition of apoptosis by Herpes Simplex virus type 2 ICP10.
Han JY; Miller SA; Wolfe TM; Pourhassan H; Jerome KR
J Virol; 2009 Mar; 83(6):2765-9. PubMed ID: 19116254
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E
BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713
[TBL] [Abstract][Full Text] [Related]
27. The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation.
Langelier Y; Bergeron S; Chabaud S; Lippens J; Guilbault C; Sasseville AM; Denis S; Mosser DD; Massie B
J Gen Virol; 2002 Nov; 83(Pt 11):2779-2789. PubMed ID: 12388814
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Chung TD; Wymer JP; Smith CC; Kulka M; Aurelian L
J Virol; 1989 Aug; 63(8):3389-98. PubMed ID: 2545912
[TBL] [Abstract][Full Text] [Related]
29. Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation.
Murata T; Goshima F; Daikoku T; Takakuwa H; Nishiyama Y
Genes Cells; 2000 Dec; 5(12):1017-27. PubMed ID: 11168588
[TBL] [Abstract][Full Text] [Related]
30. Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Chung TD; Wymer JP; Kulka M; Smith CC; Aurelian L
Virology; 1990 Nov; 179(1):168-78. PubMed ID: 2171204
[TBL] [Abstract][Full Text] [Related]
31. The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function.
Chabaud S; Sasseville AM; Elahi SM; Caron A; Dufour F; Massie B; Langelier Y
J Gen Virol; 2007 Feb; 88(Pt 2):384-394. PubMed ID: 17251554
[TBL] [Abstract][Full Text] [Related]
32. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
33. Immunologic characterization of herpes simplex virus type 2 antigens ICP10 and ICSP11/12.
Flanders RT; Kucera LS; Raben M; Ricardo MJ
Virus Res; 1985 Apr; 2(3):245-60. PubMed ID: 2988230
[TBL] [Abstract][Full Text] [Related]
34. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
Gyotoku T; Ono F; Aurelian L
Vaccine; 2002 Jun; 20(21-22):2796-807. PubMed ID: 12034107
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1).
Aurelian L; Smith CC
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):77-85. PubMed ID: 10805158
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
37. Targeting apoptosis in neurological disease using the herpes simplex virus.
Perkins D
J Cell Mol Med; 2002; 6(3):341-56. PubMed ID: 12417051
[TBL] [Abstract][Full Text] [Related]
38. A truncated protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) expressed in Escherichia coli.
Luo JH; Smith CC; Kulka M; Aurelian L
J Biol Chem; 1991 Nov; 266(31):20976-83. PubMed ID: 1657940
[TBL] [Abstract][Full Text] [Related]
39. Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis.
Choi WS; Yoon SY; Chang II; Choi EJ; Rhim H; Jin BK; Oh TH; Krajewski S; Reed JC; Oh YJ
J Neurochem; 2000 Apr; 74(4):1621-6. PubMed ID: 10737620
[TBL] [Abstract][Full Text] [Related]
40. The transmembrane helical segment but not the invariant lysine is required for the kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Luo JH; Aurelian L
J Biol Chem; 1992 May; 267(14):9645-53. PubMed ID: 1315764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
